These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Validation of a Protocol for Continuous Hemodiafiltration with Regional Citrate Anticoagulation with OmniĀ®. Whiting L; Bianchi NA; Alouazen K; Joannes-Boyau O; Chiche JD; Schneider A Blood Purif; 2022; 51(12):1039-1047. PubMed ID: 35636389 [TBL] [Abstract][Full Text] [Related]
6. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Tolwani AJ; Prendergast MB; Speer RR; Stofan BS; Wille KM Clin J Am Soc Nephrol; 2006 Jan; 1(1):79-87. PubMed ID: 17699194 [TBL] [Abstract][Full Text] [Related]
7. The Clearance of Midazolam and Metabolites during Continuous Renal Replacement Therapy in Critically Ill Patients with COVID-19. Smeets TJL; de Geus HRH; Valkenburg AJ; Baidjoe L; Gommers DAMPJ; Koch BCP; Hunfeld NGM; Endeman H Blood Purif; 2024; 53(2):107-113. PubMed ID: 37926072 [TBL] [Abstract][Full Text] [Related]
8. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy]. Gong D; Ji D; Xie H; Xu B; Liu Y; Li L Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577 [TBL] [Abstract][Full Text] [Related]
9. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Brunet S; Leblanc M; Geadah D; Parent D; Courteau S; Cardinal J Am J Kidney Dis; 1999 Sep; 34(3):486-92. PubMed ID: 10469859 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration. Wallis SC; Mullany DV; Lipman J; Rickard CM; Daley PJ Intensive Care Med; 2001 Apr; 27(4):665-72. PubMed ID: 11398692 [TBL] [Abstract][Full Text] [Related]
13. In vivo validation of the adequacy calculator for continuous renal replacement therapies. Ricci Z; Salvatori G; Bonello M; Pisitkun T; Bolgan I; D'Amico G; Dan M; Piccinni P; Ronco C Crit Care; 2005 Jun; 9(3):R266-73. PubMed ID: 15987400 [TBL] [Abstract][Full Text] [Related]
14. Continuous venovenous hemodiafiltration versus standard medical therapy for the prevention of rhabdomyolysis-induced acute kidney injury: a retrospective cohort study. Meng Y; Zhou MX; Wu CB; Wang DH; Zhao JR; Shi DY BMC Nephrol; 2023 Jul; 24(1):215. PubMed ID: 37468857 [TBL] [Abstract][Full Text] [Related]
15. Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters. Troyanov S; Cardinal J; Geadah D; Parent D; Courteau S; Caron S; Leblanc M Nephrol Dial Transplant; 2003 May; 18(5):961-6. PubMed ID: 12686672 [TBL] [Abstract][Full Text] [Related]
18. Solutes removal characteristics at various effluent rates during different continuous renal replacement therapy modalities. Yu W; Zhuang F; Ma S; Zhu M; Ding F Int J Artif Organs; 2019 Jul; 42(7):354-361. PubMed ID: 30905252 [TBL] [Abstract][Full Text] [Related]
19. A comparison of continuous renal replacement therapy to intermittent dialysis in the management of renal insufficiency in the acutely III surgical patient. Waldrop J; Ciraulo DL; Milner TP; Gregori D; Kendrick AS; Richart CM; Maxwell RA; Barker DE Am Surg; 2005 Jan; 71(1):36-9. PubMed ID: 15757054 [TBL] [Abstract][Full Text] [Related]
20. Dialyzer fiber bundle volume and kinetics of solute removal in continuous venovenous hemodialysis. Liangos O; Sakiewicz PG; Kanagasundaram NS; Hammel J; Pajouh M; Seifert T; Paganini EP Am J Kidney Dis; 2002 May; 39(5):1047-53. PubMed ID: 11979349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]